1. Go, Gwang-Woong, Mani, Arya. 2012. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. In The Yale journal of biology and medicine, 85, 19-28. doi:. https://pubmed.ncbi.nlm.nih.gov/22461740/
2. Zorzo, R A, Suen, V M M, Santos, J E, Krieger, J E, Liberatore-Jr, R D R. 2023. LDLR gene's promoter region hypermethylation in patients with familial hypercholesterolemia. In Scientific reports, 13, 9241. doi:10.1038/s41598-023-34639-1. https://pubmed.ncbi.nlm.nih.gov/37286669/
3. Abifadel, Marianne, Varret, Mathilde, Rabès, Jean-Pierre, Seidah, Nabil G, Boileau, Catherine. . Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. In Nature genetics, 34, 154-6. doi:. https://pubmed.ncbi.nlm.nih.gov/12730697/
4. Bertolini, Stefano, Pisciotta, Livia, Rabacchi, Claudio, Averna, Maurizio, Calandra, Sebastiano. 2013. Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. In Atherosclerosis, 227, 342-8. doi:10.1016/j.atherosclerosis.2013.01.007. https://pubmed.ncbi.nlm.nih.gov/23375686/
5. Ishibashi, S, Brown, M S, Goldstein, J L, Hammer, R E, Herz, J. . Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. In The Journal of clinical investigation, 92, 883-93. doi:. https://pubmed.ncbi.nlm.nih.gov/8349823/
6. Di Taranto, Maria Donata, Giacobbe, Carola, Palma, Daniela, Di Minno, Matteo Nicola Dario, Fortunato, Giuliana. 2021. Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement. In Clinical genetics, 100, 529-541. doi:10.1111/cge.14036. https://pubmed.ncbi.nlm.nih.gov/34297352/
智鼠故事 
